Public procurement notice: Contract Award Notice
Published: 2024-10-29
Buyer: SYKEHUSINNKJØP HF
Country: NO
Region: NO074
Contract type: Supplies
Procedure: Negotiated without a prior call for competition
CPV classification: 33600000: Pharmaceutical products
Estimated value: 6100000 NOK
Submission deadline: 2026-09-30
Award criteria: price, quality

Technical requirements: Sykehusinnkjøp HF, division pharmaceuticals, is collecting tenders for medicines that are used by the health authorities. It has previously been announced and held an open tender contest, 2407gj Oncology not patented medicines, where the competition included active substance in accordance with the tender documentation Annex 2 Price Form.After the implementation of the competition, a tender offer has been submitted for Cytarabin inj.100 mg/ml (product number 527755 and 462987, atc code L01BC01). There were no other tenderers in this competition for the relevant sub-contract (sub-contract 38-40). Based on this, division pharmaceuticals intends to enter into agreement between the regional health authorities (the Contracting Authorities) and Fresenius Kabi (the Supplier) in the contract 2407gj Oncology, not patented medicines, i.e. the extent and length of the contract shall follow the mentioned procurement (including access to prolongation and termination), without a new competition for this active ingredient. The health authorities that are subject to the regional health authorities have an option to join the agreement. The same applies to ideal institutions/hospitals with operational agreements with each health region. Division pharmaceuticals has examined the market situation and assesses that it is not possible with a new competition or that another supplier can deliver the product in the pending contract period, and that the situation that has arisen is conditions that are not due to the contracting authorities or that the contracting authorities could predict. Sykehusinnkjøp, division pharmaceuticals therefore believes that it is necessary to implement the procurement without competition. See the public procurement regulations § 13-4 letter b no. 3. Sykehusinnkjøp requests tenderers who may object to this intention by the end of the waiting period, which is set to 25.11.2024. If objections are not received, contracts will be signed after the waiting period expires.
Sykehusinnkjøp HF, division pharmaceuticals, is collecting tenders for medicines that are used by the health authorities. It has previously been announced and held an open tender contest, 2407gj Oncology not patented medicines, where the competition included active substance in accordance with the tender documentation's Annex 2 Price Form. After the implementation of the competition, the tenderer has entered into an agreement with the municipality that they cannot deliver goods and will, therefore, withdraw from the contract. In addition tenders have been submitted for Cytarabin inj.100 mg/ml (product number 527755 and 462987, ATC code L01BC01).
After the contract period expires, the Contracting Authority can extend all or parts of the contract for up to 1 year at a time. The total maximum agreement period is 4 years.


Number of bids: 1